WIL cozies up to Instem; GVK decries EU response to data problems;

> CRO WIL Research has deepened its ties to Instem, using the company's technology to better harmonize its data collection and reporting. Release

> India's GVK BioSciences says Europe's response to impropriety at one of the CRO's sites has been "disproportionate" with the issue. News

Suggested Articles

Genesis Drug Discovery & Development has bought up New England Discovery Partners as it looks to boost its synthetic and medicinal chemistry.

Sanofi plans to incorporate its real-world data platform with Aetion’s analytics system to better develop studies for regulatory decision-making.

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.